孕产妇和胎儿SERPINA3多态性和孕前风险:基于二和三的病例对照研究
Hsi-Hsuan Yang1, Claire Baldauf2, Trevor A Pickering1
1Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Current issues in molecular biology
|November 26, 2025
概括
这项研究研究了SERPINA3基因变异及其与妊娠高血压障碍 (HDPs) 和严重妊娠前/HELLP综合征的联系. 虽然没有发现直接关联,但父母的起源效应表明,母胎基因组不相容可能起作用.
科学领域:
- 遗传学 是一个遗传学.
- 产科 产科 产科 产科 产科
- 生殖医学 生殖医学
背景情况:
- 血清蛋白酶抑制剂A3 (SERPINA3) 与胎盘功能障碍有关.
- 妊娠高血压障碍 (HDPs),包括严重的先兆子 (sPE) 和HELLP综合征,是严重的孕产妇健康问题.
研究的目的:
- 调查SERPINA3基因多态性和与HDPs和sPE/HELLP综合征相关的类型之间的关联.
- 在这些妊娠并发症的背景下,探索原始父母的影响.
主要方法:
- 追溯病例控制研究涉及两个队列:HDP母婴二合体和sPE/HELLP母父婴三合体.
- 从DNA样本中对两个SERPINA3SNP (rs4934和rs1884082) 的基因定型.
- 使用R.R.中的Haplin包进行遗传关联分析.
主要成果:
- 在单个SERPINA3SNP或单个类型和HDP或sPE/HELLP风险之间没有发现显著的关联.
- 观察到显著的原始基因效应:rs4934的母性遗传基因降低了风险,而父性遗传基因增加了风险.
- 母亲携带两种SNP的双重副本与风险增加有关.
结论:
- 单独的SERPINA3基因多态和单元型似乎不是HDP或sPE/HELLP的主要风险因素.
- 父母的起源效应,特别是关于rs4934遗传,表明在妊娠障碍中存在潜在的母胎基因组不相容性.
更多相关视频
12:17The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo
Published on: August 2, 2017
11.1K
12:02Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
Published on: July 30, 2016
16.4K
相关概念视频
01:20Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
01:07Teratogenicity
3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K